Barnett & Company, Inc. Johnson & Johnson Transaction History

Barnett & Company, Inc.

$143 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$158.14 - $179.59 $8,855 - $10,057	-56 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$155.93 - $173.01 $8,732 - $9,688	56 New	56 $10,000
Q3 2021 Nov 04, 2021	SELL	$161.5 - $179.47 $164,084 - $182,341	-1,016 Closed	0 $0
Q2 2021 Jul 20, 2021	SELL	$159.48 - $171.07 $10,844 - $11,632	-68 Reduced 6.27%	1,016 $167,000
Q1 2021 Apr 19, 2021	SELL	$153.07 - $170.48 $19,592 - $21,821	-128 Reduced 10.56%	1,084 $178,000
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $35,237 - $40,446	-257 Reduced 17.49%	1,212 $190,000
Q3 2020 Nov 03, 2020	BUY	$140.38 - $153.83 $39,306 - $43,072	280 Added 23.55%	1,469 $219,000
Q2 2020 Jul 22, 2020	SELL	$128.81 - $155.51 $77,930 - $94,083	-605 Reduced 33.72%	1,189 $167,000
Q1 2020 Apr 23, 2020	SELL	$111.14 - $153.99 $18,893 - $26,178	-170 Reduced 8.66%	1,794 $235,000
Q4 2019 Jan 22, 2020	BUY	$127.5 - $146.44 $23,460 - $26,944	184 Added 10.34%	1,964 $287,000
Q2 2019 Jul 30, 2019	SELL	$131.15 - $144.24 $60,984 - $67,071	-465 Reduced 20.71%	1,780 $248,000
Q1 2019 Apr 26, 2019	SELL	$125.72 - $139.79 $15,715 - $17,473	-125 Reduced 5.27%	2,245 $314,000
Q4 2018 Feb 15, 2019	SELL	$122.84 - $147.84 $22,111 - $26,611	-180 Reduced 7.06%	2,370 $306,000
Q3 2018 Nov 02, 2018	BUY	$121.58 - $142.88 $164,133 - $192,888	1,350 Added 112.5%	2,550 $352,000
Q2 2018 Aug 03, 2018	BUY	$119.4 - $131.76 $2,985 - $3,294	25 Added 2.13%	1,200 $146,000
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $26,646 - $31,553	213 Added 22.14%	1,175 $151,000
Q4 2017 Feb 02, 2018	BUY	$131.22 - $143.62 $40,284 - $44,091	307 Added 46.87%	962 $134,000
Q3 2017 Nov 20, 2017	BUY	$129.47 - $135.38 $84,802 - $88,673	655	655 $85,000

Others Institutions Holding JNJ

# of Institutions

4,276

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barnett & Company, Inc. with notifications on news.

Account